This study reports the identification and genomic characteristics of Salmonella strains isolated from a blood sample of a 9-year-old male Persian cat with a systemic infection (strain M885) and from a pleural effusion sample of a 9-year-old male Bulldog (strain T886) in Brazil. Genomic DNA was sequenced using the Illumina NextSeq platform, de novo assembled by SPAdes version 3.15.2, and annotated by the RAST server. Serovars, sequence types (STs), antimicrobial resistance genes, plasmid replicons, Salmonella pathogenicity islands, and single nucleotide polymorphism (SNP) analysis were accomplished by bioinformatic tools. Strains M885 and T886 belonged to the serovars Sandiego (ST126) and Minnesota (ST548), respectively. Strain T886 carried blaCMY-2 and qnrB19 onto IncC2 and Col(pHAD28) plasmids, respectively. The blaCMY-2-bearing IncC2 plasmid also harboured mercury tolerance genes and the yersiniabactin virulence gene cluster, being classified as a type 2 IncC megaplasmid of antimicrobial resistance and virulence (plasmid for emergent S. Minnesota [pESM]). SNP-based analysis revealed clonal relatedness between the T886 strain and a CMY-2-producing S. Minnesota ST548 previously isolated from chicken sausage in Brazil, supporting a common ancestral origin. This study underscores the importance of monitoring S. enterica as the causative agent of extra-intestinal infections in small animal medicine. Therefore, the transmission dynamics and effective strategies for managing infections produced by multidrug-resistant clones adapted to the human-animal-environmental interface warrant further investigation.
28 October 2024 in Journal of Antimicrobial Chemotherapy
Klebsiella pneumoniae producing KPC variants conferring resistance to ceftazidime–avibactam often remain susceptible to meropenem, suggesting a potential therapeutic use of this antibiotic. In this study, the efficacy of clinically relevant concentrations of meropenem was evaluated against high-risk clones of ceftazidime–avibactam-resistant K. pneumoniae strains producing KPC variants, in a tandem in vitro time-kill/in vivo Galleria mellonella survival model. In vitro/in vivo efficacy of meropenem against ceftazidime–avibactam-resistant K. pneumoniae of CG16, CG25 and CG258, producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114 variants, was evaluated using EUCAST dosing recommendation adjusted to the G. mellonella model. For in vivo assays, untreated, meropenem (40 mg/kg × 1)-treated and ceftazidime–avibactam (40 mg/kg ceftazidime–10 mg/kg avibactam × 1)-treated groups were established, with 60 larvae per group. Kaplan–Meier curves, log-rank tests, univariate Cox regression and hazard ratios (HR) were used to assess treatment effects (P < 0.05). For all KPC-variant producers, time-kill assays showed >3 log-kills reduction (−6.91 ± 1.28 SD) after 6 h interaction when exposed to 8–32 mg/L meropenem MIC values (i.e. ≥ × 4 MIC). In the assessment of in vivo efficacy of meropenem, at the 4-day follow-up, mortality rates were 96.7% (untreated), 83.3% (ceftazidime–avibactam-treated) and 13.3% (meropenem-treated) (P < 0.05). Univariate Cox regression analysis showed significantly lower risk in the meropenem group compared to untreated group [HR 0.02 (95% CI: 0.01–0.05)]. These pre-clinical results might support use of meropenem as a potential alternative for treatment of infections due to KPC-variant producers displaying in vitro susceptibility to meropenem.
The acquisition of virulence determinants has led to the emergence of certain lineages of extraintestinal pathogenic Escherichia coli (ExPEC), with implications for both human and veterinary medicine. Avian Pathogenic E. coli (APEC) is a specific subpathotype of the broader ExPEC category. This study documents the occurrence of ExPEC/APEC ST162 among seven psittacine birds confiscated from the illegal wildlife trade and housed in a rehabilitation center, and describes temporal phylogenetic patterns compatible with possible within-center circulation, through a descriptive genomic surveillance approach. Whole-genome sequencing (WGS) was performed to characterize the virulome and resistome of all isolates and to comparative phylogenomic analysis of avian ST162 genomes with publicly available ST162 genomes from humans, including uropathogenic E. coli (UPEC). The first ST162 isolate was detected in a single bird early during the rehabilitation period. All isolates display similar virulence profiles. Strikingly, three out of seven ExPEC/APEC ST162 were classified as multidrug-resistant, carrying genes and/or mutations conferring resistance to clinically relevant antibiotics. Phylogenomic analysis clustered five psittacine isolates within a clade (52-1753 SNP differences) predominantly composed of human ExPEC ST162, underscoring their One Health significance at the human-animal interface. These results underscore the importance of animal-based genomic surveillance in wildlife rehabilitation centers and highlight the illegal wildlife trade as a potential pathway for the dissemination of ExPEC lineages of epidemiologic and public health relevance.